☆Artia Global Partners LP
Quality Q
0.290
AUM ($M)
526
Positions
47
Turnover
0.28
Top-10 wt
66%
Herfindahl
0.060
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 55 positions · portfolio value $526M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ABVX funds › | ABIVAX SA | TRIM | — | 13.1% | -2.0% | 68.8 | 516,447 | -84,300 | 4 | — |
| ☆INSM funds › | INSMED INC | TRIM | — | 11.9% | -11.2% | 62.8 | 589,052 | -39,660 | 5 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | ADD | — | 7.8% | +2.4% | 41.2 | 2,210,852 | +197,250 | 5 | — |
| ☆BTSG funds › | BRIGHTSPRING HEALTH SVCS INC | ADD | — | 6.9% | +6.3% | 36.1 | 517,315 | +463,515 | 4 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 6.6% | +3.9% | 34.7 | 185,390 | +60,400 | 5 | — |
| ☆ARGX funds › | ARGENX SE | HOLD | — | 5.2% | +0.3% | 27.6 | 29,739 | +0 | 5 | — |
| ☆ALKS funds › | ALKERMES PLC | NEW | — | 4.5% | +4.5% | 23.5 | 448,964 | +448,964 | 1 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | ADD | — | 3.7% | +3.2% | 19.3 | 339,033 | +268,333 | 5 | — |
| ☆AZN funds › | ASTRAZENECA PLC | ADD | — | 3.5% | -0.7% | 18.7 | 98,376 | +3,000 | 2 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | HOLD | — | 3.2% | -0.4% | 17.1 | 503,936 | +0 | 5 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | HOLD | — | 3.0% | -0.1% | 15.9 | 162,990 | +0 | 4 | — |
| ☆DGX funds › | QUEST DIAGNOSTICS INC | ADD | — | 2.6% | +0.8% | 13.8 | 65,122 | +24,305 | 5 | — |
| ☆IONS funds › | IONIS PHARMACEUTICALS INC | HOLD | — | 2.2% | -0.3% | 11.4 | 144,376 | +0 | 4 | — |
| ☆EYPT funds › | EYEPOINT INC | HOLD | — | 2.1% | -0.1% | 11.0 | 767,098 | +0 | 5 | — |
| ☆ALMS funds › | ALUMIS INC | TRIM | — | 1.5% | -0.1% | 7.8 | 278,546 | -46,500 | 2 | — |
| ☆VKTX funds › | VIKING THERAPEUTICS INC | HOLD | — | 1.3% | +0.0% | 7.1 | 180,731 | +0 | 5 | — |
| ☆CELC funds › | CELCUITY INC | ADD | — | 1.2% | +0.8% | 6.2 | 59,316 | +43,740 | 3 | — |
| ☆CYTK funds › | CYTOKINETICS INC | ADD | — | 1.1% | +0.9% | 6.0 | 70,700 | +54,400 | 2 | — |
| ☆MRK funds › | MERCK & CO INC | HOLD | — | 1.1% | -0.1% | 6.0 | 46,700 | +0 | 2 | — |
| ☆RAPP funds › | RAPPORT THERAPEUTICS INC | HOLD | — | 1.1% | +0.1% | 5.8 | 138,508 | +0 | 4 | — |
| ☆JNJ funds › | JOHNSON & JOHNSON | HOLD | — | 1.1% | -0.2% | 5.7 | 22,600 | +0 | 2 | — |
| ☆GH funds › | GUARDANT HEALTH INC | NEW | — | 1.1% | +1.1% | 5.7 | 38,100 | +38,100 | 1 | — |
| ☆ABSI funds › | ABSCI CORPORATION | NEW | Common Stock | 1.0% | +1.0% | 5.4 | 464,444 | +464,444 | 1 | — |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | HOLD | — | 1.0% | -0.1% | 5.3 | 96,285 | +0 | 5 | — |
| ☆SION funds › | SIONNA THERAPEUTICS INC | HOLD | — | 1.0% | -0.1% | 5.3 | 119,741 | +0 | 3 | — |
| ☆ASND funds › | ASCENDIS PHARMA A/S | NEW | — | 0.9% | +0.9% | 4.7 | 17,740 | +17,740 | 1 | — |
| ☆CUSIP:G76279101 funds › | ROIVANT SCIENCES LTD | HOLD | — | 0.9% | +0.1% | 4.6 | 129,800 | +0 | 3 | — |
| ☆PALI funds › | PALISADE BIO INC | HOLD | — | 0.8% | +0.0% | 4.2 | 1,992,367 | +0 | 3 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | ADD | — | 0.8% | +0.3% | 4.0 | 98,800 | +33,300 | 2 | — |
| ☆BIIB funds › | BIOGEN INC | HOLD | — | 0.8% | -0.0% | 4.0 | 18,437 | +0 | 2 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 0.7% | -0.1% | 3.9 | 65,000 | +0 | 5 | — |
| ☆BLTE funds › | BELITE BIO INC | HOLD | — | 0.7% | -0.2% | 3.8 | 24,989 | +0 | 3 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | HOLD | — | 0.7% | -0.1% | 3.7 | 137,800 | +0 | 5 | — |
| ☆PROK funds › | PROKIDNEY CORP | HOLD | — | 0.7% | -0.0% | 3.7 | 1,806,939 | +0 | 3 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | ADD | — | 0.7% | +0.5% | 3.7 | 72,100 | +51,200 | 2 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | NEW | — | 0.6% | +0.6% | 3.2 | 33,400 | +33,400 | 1 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | ADD | — | 0.5% | -0.0% | 2.8 | 22,951 | +20 | 5 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | HOLD | — | 0.5% | -0.2% | 2.7 | 5,000 | +0 | 5 | — |
| ☆DRUG funds › | BRIGHT MINDS BIOSCIENCES INC | HOLD | — | 0.5% | -0.1% | 2.7 | 38,407 | +0 | 3 | — |
| ☆KNSA funds › | KINIKSA PHARMACEUTICALS INTL | HOLD | — | 0.4% | +0.0% | 1.9 | 29,200 | +0 | 5 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | NEW | — | 0.2% | +0.2% | 0.8 | 383,200 | +383,200 | 1 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | HOLD | — | 0.2% | -0.0% | 0.8 | 2,500 | +0 | 3 | — |
| ☆KOD funds › | KODIAK SCIENCES INC | HOLD | — | 0.1% | -0.0% | 0.7 | 17,019 | +0 | 3 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 0.6 | 42,080 | +0 | 3 | — |
| ☆NUVL funds › | NUVALENT INC | HOLD | — | 0.1% | +0.0% | 0.6 | 4,900 | +0 | 3 | — |
| ☆PEPG funds › | PEPGEN INC | HOLD | — | 0.1% | -0.0% | 0.4 | 205,324 | +0 | 3 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.4 | 4,000 | +4,000 | 1 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -5,886 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -68,490 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.2% | 0.0 | 0 | -104,800 | 0 | — |
| ☆LLY funds › | ELI LILLY & CO | EXIT | — | 0.0% | -7.9% | 0.0 | 0 | -38,220 | 0 | — |
| ☆ABBV funds › | ABBVIE INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -14,500 | 0 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -20,400 | 0 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -28,970 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -17,740 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 526 | 47 | 0.28 | 66% | 0.060 | 0.290 | — | in |
| 2026Q1 | 444 | 48 | 0.29 | 73% | 0.096 | 0.329 | — | in |
| 2025Q4 | 622 | 50 | 0.35 | 72% | 0.081 | 0.215 | — | in |
| 2025Q3 | 568 | 48 | 0.28 | 71% | 0.074 | 0.317 | — | in |
| 2025Q2 | 389 | 33 | 0.42 | 87% | 0.123 | 0.204 | — | entered |
| 2025Q1 | 341 | 32 | 0.00 | 81% | 0.099 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status